These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29980535)

  • 21. Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue.
    Preitner F; Muzzin P; Revelli JP; Seydoux J; Galitzky J; Berlan M; Lafontan M; Giacobino JP
    Br J Pharmacol; 1998 Aug; 124(8):1684-8. PubMed ID: 9756384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brown Adipose Tissue Activation in Humans Increases Plasma Levels of Lipid Mediators.
    Walker ME; Kodani SD; Mena HA; Tseng YH; Cypess AM; Spite M
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1837-1849. PubMed ID: 38198796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats.
    Gómez-Ambrosi J; Frühbeck G; Aguado M; Milagro FI; Margareto J; Martínez AJ
    Int J Mol Med; 2001 Jul; 8(1):103-9. PubMed ID: 11408957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor.
    Fletcher DS; Candelore MR; Grujic D; Lowell BB; Luell S; Susulic VS; Macintyre DE
    J Pharmacol Exp Ther; 1998 Nov; 287(2):720-4. PubMed ID: 9808702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute metabolic and cardiovascular effects of mirabegron in healthy individuals.
    Loh RKC; Formosa MF; La Gerche A; Reutens AT; Kingwell BA; Carey AL
    Diabetes Obes Metab; 2019 Feb; 21(2):276-284. PubMed ID: 30203462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Mirabegron on the Body's Exercise Capacity: A Review.
    Leis K; Mazur E; Racinowski M; Świerczyński W; Baska A; Gałązka P
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1448-1455. PubMed ID: 32416711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Brown Adipocyte Thermogenesis Is Driven by β2-AR Stimulation.
    Blondin DP; Nielsen S; Kuipers EN; Severinsen MC; Jensen VH; Miard S; Jespersen NZ; Kooijman S; Boon MR; Fortin M; Phoenix S; Frisch F; Guérin B; Turcotte ÉE; Haman F; Richard D; Picard F; Rensen PCN; Scheele C; Carpentier AC
    Cell Metab; 2020 Aug; 32(2):287-300.e7. PubMed ID: 32755608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of age on beta adrenergic subtype activation of adenylyl cyclase in brown adipose tissue.
    Scarpace PJ; Dove J; Matheny M
    Proc Soc Exp Biol Med; 1996 Dec; 213(3):262-7. PubMed ID: 8985310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.
    Konkar AA; Zhai Y; Granneman JG
    Mol Pharmacol; 2000 Feb; 57(2):252-8. PubMed ID: 10648634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis.
    Sui W; Li H; Yang Y; Jing X; Xue F; Cheng J; Dong M; Zhang M; Pan H; Chen Y; Zhang Y; Zhou Q; Shi W; Wang X; Zhang H; Zhang C; Zhang Y; Cao Y
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10937-10942. PubMed ID: 31085638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrical Neurostimulation Promotes Brown Adipose Tissue Thermogenesis.
    Li Z; de Jonge WJ; Wang Y; Rensen PCN; Kooijman S
    Front Endocrinol (Lausanne); 2020; 11():567545. PubMed ID: 33101199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brown adipose tissue thermogenesis: β3-adrenoreceptors as a potential target for the treatment of obesity in humans.
    Mund RA; Frishman WH
    Cardiol Rev; 2013; 21(6):265-9. PubMed ID: 23707990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of ADAMTS5 enhances brown adipose tissue mass and promotes browning of white adipose tissue via CREB signaling.
    Bauters D; Cobbaut M; Geys L; Van Lint J; Hemmeryckx B; Lijnen HR
    Mol Metab; 2017 Jul; 6(7):715-724. PubMed ID: 28702327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of the β
    Dumont L; Caron A; Richard G; Croteau E; Fortin M; Frisch F; Phoenix S; Dubreuil S; Guérin B; Turcotte ÉE; Carpentier AC; Blondin DP
    Acta Physiol (Oxf); 2024 May; 240(5):e14127. PubMed ID: 38502056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Brown and White Adipocyte Transcriptome by the Transcriptional Coactivator NT-PGC-1α.
    Kim J; Fernand VE; Henagan TM; Shin J; Huypens P; Newman S; Gettys TW; Chang JS
    PLoS One; 2016; 11(7):e0159990. PubMed ID: 27454177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of beta3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition: evidence for a role of insulin.
    Hadri KE; Charon C; Pairault J; Hauguel-De Mouzon S; Quignard-Boulangé A; Fève B
    Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):359-64. PubMed ID: 9163324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG Uptake in Brown Adipose Tissue Activated by a β3-Adrenergic Receptor Agonist Prescribed for Overactive Bladder.
    Okuyama C; Kikuchi R; Ikeuchi T
    Clin Nucl Med; 2020 Aug; 45(8):628-631. PubMed ID: 32453085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans.
    Finlin BS; Memetimin H; Zhu B; Confides AL; Vekaria HJ; El Khouli RH; Johnson ZR; Westgate PM; Chen J; Morris AJ; Sullivan PG; Dupont-Versteegden EE; Kern PA
    J Clin Invest; 2020 May; 130(5):2319-2331. PubMed ID: 31961829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21.
    Chartoumpekis DV; Habeos IG; Ziros PG; Psyrogiannis AI; Kyriazopoulou VE; Papavassiliou AG
    Mol Med; 2011; 17(7-8):736-40. PubMed ID: 21373720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis.
    Talamonti E; Davegardh J; Kalinovich A; van Beek SMM; Dehvari N; Halleskog C; Bokhari HM; Hutchinson DS; Ham S; Humphrys LJ; Dijon NC; Motso A; Sandstrom A; Zacharewicz E; Mutule I; Suna E; Spura J; Ditrychova K; Stoddart LA; Holliday ND; Wright SC; Lauschke VM; Nielsen S; Scheele C; Cheesman E; Hoeks J; Molenaar P; Summers RJ; Pelcman B; Yakala GK; Bengtsson T
    Mol Metab; 2024 Jul; 85():101931. PubMed ID: 38796310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.